Polyclonal Antibody to Pyruvate Dehydrogenase Complex Component X (PDHX)
| Code | Size | Price |
|---|
| PAH426Mu01-20ul | 20ul | £88.00 |
Quantity:
| PAH426Mu01-100ul | 100ul | £165.00 |
Quantity:
| PAH426Mu01-200ul | 200ul | £223.00 |
Quantity:
| PAH426Mu01-1ml | 1ml | £512.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Mouse
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunocytochemistry (ICC)
- Immunohistochemistry- Frozen Section (IHC-F)
- Immunohistochemistry- Paraffin Embedded (IHC-P)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
E3BP; proX; PDX1; OPDX; DLDBP; E3-binding protein; Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex
Buffer Formulation:
0.01M PBS, pH7.4, containing 0.01% Proclin-300, 50% glycerol.
Item Name:
Pyruvate Dehydrogenase Complex Component X
Source:
Polyclonal antibody preparation
Usage:
Western blotting: 0.5-2ug/mL;1:300-1200<br/>Immunohistochemistry: 5-20ug/mL;1:30-120<br/>Immunocytochemistry: 5-20ug/mL;1:30-120<br/>Optimal working dilutions must be determined by end user.
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Pyruvate Dehydrogenase Complex Component X (PDHX) | RPH426Mu01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||